RealTime Laboratories

[Guest guest]

Company History

http://www.realtimelab.com/index.htm

RealTime Laboratories, LLC is providing unique testing that will

help in evaluating patients with health problems from suspected mold

exposure. How did the testing that RealTime use come about and why

is it not offered by other laboratories?

In 1999, Dennis Hooper, M.D., Ph.D. was sought out by a family in

Southern California to help find the cause of their mother's death.

Their mother's autopsies did not show a definitive cause of death,

but their Mother had been exposed to a very high level of mold

exposure from her contaminated house. The autopsy listed the cause

of death as cardiopulmonary arrest. This diagnosis on a death

certificate is often used when an apparent cause of death cannot be

found. At that time there was not a reliable methodology for the

identification of mold infections in human tissue, therefore, deaths

would be ruled as being due to cardiopulmonary arrest, respiratory

arrest, SIDS or other common (and less investigated) causes. Dr.

Hooper with training in both pathology and microbiology realized

that a link between mold exposure and the cause of deaths in the

case he was investigating could possibly exist.

He knew that the cause of death in a person who has lived in a mold

contaminated environment may not be apparent since current

laboratory technology and methods were unable to detect molds and

their mycotoxins as causative agents. Dr. Hooper's review of the

autopsy results on his first case, when evaluated by traditional

methods, in fact did not yield any findings that showed the patient

had mold exposure. This puzzling death caused Dr. Hooper to set out

on a quest to develop methods for the identification of mold in

human tissues.

Dr. Hooper was familiar with techniques and methods for the

identification of mold spores and their mycotoxins from other work

in agricultural studies. By using the technology from his work as a

microbiologist, he was able to develop and perform testing that

could identify various mycotoxins along with the mycotoxin-producing

molds. He proceeded to evaluate his techniques and modify them for

use in human testing. After reevaluating the Southern California

case using his new techniques, Dr. Hooper was able to demonstrate

that the patient had mold present in her tissues.

This was the solution to the puzzle: mold was most likely the agent

that caused her respiratory arrest resulting in her death.

Over the next three years, Dr. Hooper performed a number of other

autopsies again, where the cause of death in these cases was often

not readily apparent but patients had histories of high mold

exposures. Again, at the time there was not a reliable methodology

for the identification of mold infections in human tissue,

therefore, deaths would be ruled as being due to cardiopulmonary

arrest, respiratory arrest, SIDS or other common (and less

investigated) causes. With his new methods, however a number of

cases, when retested, resulted in findings consistent with the death

due to mold infections and/or exposure.

In 2004, Dr. Hooper teamed with long time colleague, Bolton,

M.D. with whom he had been working with in medical school doing

research finding causations for different infectious diseases.

Along with Dr. Bolton and his business partner Modesto Regina, MBA,

Dr. Hooper continued to develop and validated the testing now

offered by RealTime Laboratories.

Test development was performed in a CLIA-certified laboratory in

Dallas, Texas and in 2006 resulted in patent filings for their

products and procedures.

RealTime Laboratories is now the home of this new technology for

testing for mold infections!

RealTime Laboratories, LLC

8325 Walnut Hill Lane, Suite 125 * Dallas, Texas 75231 * Phone:

214.890.1199 * Fax: 214.890.1189

Email: contact@...

[Guest guest]

I guess i am lucky that my doctors use that lab.

tigerpaw2c <tigerpaw2c@...> wrote:

Company History

http://www.realtimelab.com/index.htm

RealTime Laboratories, LLC is providing unique testing that will

help in evaluating patients with health problems from suspected mold

exposure. How did the testing that RealTime use come about and why

is it not offered by other laboratories?

In 1999, Dennis Hooper, M.D., Ph.D. was sought out by a family in

Southern California to help find the cause of their mother's death.

Their mother's autopsies did not show a definitive cause of death,

but their Mother had been exposed to a very high level of mold

exposure from her contaminated house. The autopsy listed the cause

of death as cardiopulmonary arrest. This diagnosis on a death

certificate is often used when an apparent cause of death cannot be

found. At that time there was not a reliable methodology for the

identification of mold infections in human tissue, therefore, deaths

would be ruled as being due to cardiopulmonary arrest, respiratory

arrest, SIDS or other common (and less investigated) causes. Dr.

Hooper with training in both pathology and microbiology realized

that a link between mold exposure and the cause of deaths in the

case he was investigating could possibly exist.

He knew that the cause of death in a person who has lived in a mold

contaminated environment may not be apparent since current

laboratory technology and methods were unable to detect molds and

their mycotoxins as causative agents. Dr. Hooper's review of the

autopsy results on his first case, when evaluated by traditional

methods, in fact did not yield any findings that showed the patient

had mold exposure. This puzzling death caused Dr. Hooper to set out

on a quest to develop methods for the identification of mold in

human tissues.

Dr. Hooper was familiar with techniques and methods for the

identification of mold spores and their mycotoxins from other work

in agricultural studies. By using the technology from his work as a

microbiologist, he was able to develop and perform testing that

could identify various mycotoxins along with the mycotoxin-producing

molds. He proceeded to evaluate his techniques and modify them for

use in human testing. After reevaluating the Southern California

case using his new techniques, Dr. Hooper was able to demonstrate

that the patient had mold present in her tissues.

This was the solution to the puzzle: mold was most likely the agent

that caused her respiratory arrest resulting in her death.

Over the next three years, Dr. Hooper performed a number of other

autopsies again, where the cause of death in these cases was often

not readily apparent but patients had histories of high mold

exposures. Again, at the time there was not a reliable methodology

for the identification of mold infections in human tissue,

therefore, deaths would be ruled as being due to cardiopulmonary

arrest, respiratory arrest, SIDS or other common (and less

investigated) causes. With his new methods, however a number of

cases, when retested, resulted in findings consistent with the death

due to mold infections and/or exposure.

In 2004, Dr. Hooper teamed with long time colleague, Bolton,

M.D. with whom he had been working with in medical school doing

research finding causations for different infectious diseases.

Along with Dr. Bolton and his business partner Modesto Regina, MBA,

Dr. Hooper continued to develop and validated the testing now

offered by RealTime Laboratories.

Test development was performed in a CLIA-certified laboratory in

Dallas, Texas and in 2006 resulted in patent filings for their

products and procedures.

RealTime Laboratories is now the home of this new technology for

testing for mold infections!

RealTime Laboratories, LLC

8325 Walnut Hill Lane, Suite 125 * Dallas, Texas 75231 * Phone:

214.890.1199 * Fax: 214.890.1189

Email: contact@...

---------------------------------

Sneak preview the all-new .com. It's not radically different. Just

radically better.